Literature DB >> 2646862

Genetically engineered antibody molecules.

S L Morrison1, V T Oi.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2646862     DOI: 10.1016/s0065-2776(08)60640-9

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


× No keyword cloud information.
  8 in total

1.  Homodimerization of tumor-reactive monoclonal antibodies markedly increases their ability to induce growth arrest or apoptosis of tumor cells.

Authors:  M A Ghetie; E M Podar; A Ilgen; B E Gordon; J W Uhr; E S Vitetta
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

2.  Engineering subunit association of multisubunit proteins: a dimeric streptavidin.

Authors:  T Sano; S Vajda; C L Smith; C R Cantor
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

3.  Human monoclonal antibodies against Pseudomonas aeruginosa lipopolysaccharide derived from transgenic mice containing megabase human immunoglobulin loci are opsonic and protective against fatal pseudomonas sepsis.

Authors:  S Hemachandra; K Kamboj; J Copfer; G Pier; L L Green; J R Schreiber
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

4.  Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant.

Authors:  P H Hand; B Calvo; D Milenic; T Yokota; M Finch; P Snoy; K Garmestani; O Gansow; J Schlom; S V Kashmiri
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

Review 5.  Antibody phage display libraries: contributions to oncology.

Authors:  Carmela Dantas-Barbosa; Marcelo De Macedo Brigido; Andrea Queiroz Maranhao
Journal:  Int J Mol Sci       Date:  2012-05-04       Impact factor: 6.208

6.  Mouse-human chimeric antibody MH171 against the multidrug transporter P-glycoprotein.

Authors:  K Ariyoshi; H Hamada; M Naito; Y Heike; H Seimiya; K Maezawa; T Tsuruo
Journal:  Jpn J Cancer Res       Date:  1992-05

Review 7.  Phage Display Derived Monoclonal Antibodies: From Bench to Bedside.

Authors:  Mohamed A Alfaleh; Hashem O Alsaab; Ahmad Bakur Mahmoud; Almohanad A Alkayyal; Martina L Jones; Stephen M Mahler; Anwar M Hashem
Journal:  Front Immunol       Date:  2020-08-28       Impact factor: 7.561

Review 8.  Therapeutic applications of monoclonal antibodies.

Authors:  Mitchell Berger; Vidya Shankar; Abbas Vafai
Journal:  Am J Med Sci       Date:  2002-07       Impact factor: 2.378

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.